Sarepta Shares Bounce As Pfizer’s DMD Gene Therapy Sparks Safety Concerns

Baseball
Sarepta bounces on Pfizer data but will it win the game? • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Gene Therapies

More from Advanced Therapies